Overall survival in stage IV EGFR mutationpositive NSCLC: Comparing first, second and thirdgeneration EGFRTKIs (Review). Vaid AK, Gupta A, Momi G. Int J Oncol 2021;58:171-184.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Vaid AK, Gupta A, Momi G. Overall survival in stage IV EGFR mutationpositive NSCLC: Comparing first, second and thirdgeneration EGFRTKIs (Review). Int J Oncol 2021;58:171-184.
PMID: 33491758